# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The FDA is investigating concerns about metals in tampons after a 2024 study. The agency is conducting an internal study and re...
Two popular momentum indicators simultaneously showed overbought conditions in Proctor and Gamble to be overbought. A move lowe...
DZ Bank analyst Michael Pohn upgrades Procter & Gamble (NYSE:PG) from Hold to Buy and announces $190 price target.